CAS: 718612-62-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Irinotecan-d10 HCl REF: 4Z-I-181CAS: 718612-62-5 | - - - | To inquire | Tue 10 Dec 24 |
 | Irinotecan-d10 Hydrochloride (Major) REF: TR-I767502CAS: 718612-62-5 | - - - | 275.00 €~1,818.00 € | Thu 19 Dec 24 |
 | Irinotecan-d10 Hydrochloride (Major) REF: 3D-TDB61262CAS: 718612-62-5 | Min. 95% | To inquire | Tue 21 Jan 25 |
Irinotecan-d10 HCl
CAS:718612-62-5
Formula:
C33H28D10N4O6·HCl
Color and Shape:
Yellow Solid
Molecular weight:
596.75 36.46
Ref: 4Z-I-181
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Irinotecan-d10 Hydrochloride (Major)
Controlled ProductCAS:718612-62-5
Applications Deuterated Irinotecan, a DNA topoisomerase inhibitor. References Kunimoto, T., et al.: Cancer Res., 47, …
Formula:
C33H29D10ClN4O6
Color and Shape:
Neat
Molecular weight:
633.2
Ref: TR-I767502
| 1mg | 275.00 € | ||
| 10mg | 1,818.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Irinotecan-d10 Hydrochloride (Major)
CAS:718612-62-5
Irinotecan is a chemotherapeutic drug used in the treatment of colon, lung and breast cancers. …
Formula:
C33H29D10ClN4O6
Purity:
Min. 95%
Molecular weight:
633.2 g/mol
Ref: 3D-TDB61262
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
